The Memorandum of Understanding (MoU) has been agreed between NHS England, the Association of the British Pharmaceutical Industry (ABPI) and the British Generics Manufacturers Association (BGMA).
NHS England and the Pharmaceutical Industry share mutual ambitions in improving health outcomes and quality of care, and the objectives of facilitating high quality, care for all and improving patient outcomes both now and in the future through the use of medicines that help patients and those who support them in providing effective and cost-effective practice.
The Pharmaceutical Industry Sector Partnership has been established with the ABPI and the BGMA as a sector board of the Industry Council. The Board provides a forum for NHS England, ABPI and BGMA to progress shared objectives by identifying and tackling key issues of mutual interest. It also provides an opportunity to develop a better mutual understanding and sharing of expertise through knowledge and role exchanges.
The Memorandum of Understanding (MoU) sets out the nature of the partnership between NHS England, ABPI and BGMA through the PISP, and provides a framework within which all parties can address strategic issues of mutual interest.”